Rubin, M., Maccagno, M., Maggiore, M., Pistone, A., Macioce, A., Tagliero, R., Arena, G., Piane, S., Voena, C., Chiarle, R. (2025). Pharmacologic overactivation of ALK activity by PTPN2/PTPN1 inhibition induces a combination of tumor-intrinsic oncogenic stress and immune responses to promote tumor eradication in ALK-positive lymphoma. Blood. https://doi.org/10.1182/blood-2025-1772